OSR Holdings, Inc.

Biotechnology • Healthcare • Bellevue, WA, United States • OSRHW (NCM)

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.

425 635 7700 10900 NE 4th Street, Bellevue, WA 98004, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity - PR Newswire

PR Newswire • Sep 9

Woori IO shareholders approve final step in OSR Holdings acquisition - Investing.com

Investing.com • Dec 19

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target - TMX Newsfile

TMX Newsfile • Oct 20

OSR Holdings Major Leap: What’s Ahead? - StocksToTrade

StocksToTrade • Aug 25

OSR Holdings (NASDAQ: OSRH) pilot shows 5% CV precision, r>0.900 correlation for Glucheck - Stock Titan

Stock Titan • Nov 6

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has OSR Holdings, Inc. had layoffs?

No layoff events have been recorded for OSR Holdings, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does OSR Holdings, Inc. have?

OSR Holdings, Inc. has approximately 19 employees.

What industry is OSR Holdings, Inc. in?

OSR Holdings, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is OSR Holdings, Inc. a publicly traded company?

Yes, OSR Holdings, Inc. is publicly traded under the ticker symbol OSRHW on the NCM.

Where is OSR Holdings, Inc. headquartered?

OSR Holdings, Inc. is headquartered in Bellevue, WA, United States at 10900 NE 4th Street, Bellevue, WA 98004, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.